About Neologicals
Built by scientists. Driven by patients.
We are a team of drug developers, scientists, and operators who have spent careers building medicines — and who came together to do it differently.
Our story
Why we started Neologicals
Neologicals was founded on a simple conviction: the most important medicines of the next decade will come from mechanisms that the industry has overlooked. Not because the biology isn't compelling — but because the risk tolerance, the timelines, and the incentive structures of large pharma make it hard to pursue truly novel science.
Our founders spent years inside large pharmaceutical companies and academic research centers watching promising programs get shelved — not because they failed scientifically, but because they didn't fit the portfolio strategy of the quarter. We started Neologicals to be the company that picks those programs up.
We are patient-first in the most literal sense: every program we advance starts with a patient population that has no good options. That constraint focuses us. It keeps us honest. And it makes the work matter.
What we believe
Our values
Rigorous science, always
We don't advance programs on hope. Every candidate earns its place through mechanistic validation, patient-relevant models, and honest assessment of the data — even when the data disappoints.
Patients before portfolio
We choose programs based on unmet need, not market size. If the biology is right and the patients are waiting, we find a way to advance it.
Transparency with partners
We tell investors, collaborators, and advisors what we know — and what we don't. Trust is built on honest communication, especially when the news is hard.
Long-term thinking
Drug development is a decade-long endeavor. We make decisions that are right for the programs and the patients, not the next board meeting.
Join us in redefining what's possible
We're always looking for exceptional scientists, operators, and partners who share our conviction that the best medicines are still ahead of us.